Immediate Impact
49 standout
Citing Papers
HER2-targeted therapies in cancer: a systematic review
2024 Standout
Mechanisms of metastatic colorectal cancer
2024 Standout
Works of Irene Pecora being referenced
Rationale and Study Design of the PARERE Trial: Randomized phase II Study of Panitumumab Re-Treatment Followed by Regorafenib Versus the Reverse Sequence in RAS and BRAF Wild-Type Chemo-Refractory Metastatic Colorectal Cancer Patients
2021
HER2 Overexpression as a Poor Prognostic Determinant in Resected Biliary Tract Cancer
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Irene Pecora | 125 | 92 | 32 | 68 | 22 | 196 | |
| Ina Valeria Zurlo | 99 | 85 | 37 | 42 | 23 | 181 | |
| Carrie Luu | 167 | 86 | 38 | 94 | 32 | 283 | |
| Maria Grazia Rodriquenz | 143 | 95 | 49 | 60 | 27 | 264 | |
| Yoshiki Horie | 173 | 155 | 24 | 98 | 30 | 251 | |
| Azusa Komori | 142 | 124 | 16 | 103 | 27 | 247 | |
| Chao‐Wen Hsu | 116 | 85 | 33 | 125 | 28 | 268 | |
| Phillipe Taniere | 109 | 92 | 60 | 63 | 23 | 263 | |
| Changsen Leng | 106 | 71 | 30 | 131 | 20 | 278 | |
| Fitzgerald Pj | 146 | 45 | 18 | 145 | 25 | 268 | |
| Tadayoshi Hashimoto | 91 | 161 | 36 | 154 | 36 | 262 |
All Works
Login with ORCID to disown or claim papers
Loading papers...